Detechgene
PrivateLast Round
Seed
Aug 25, 2025
Total Funding Raised
$6.28M
Company Overview
Detechgene operates in Healthcare & Life Sciences and is based in Cologne. Its latest recorded funding round was a Seed round in August 2025.
Detechgene is a biotechnology company that develops a mobile rapid molecular diagnostic platform for the detection of viral, bacterial, and fungal pathogens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Detechgene Comparables
Compare Detechgene with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anavasi Diagnostics | 87% | |
| GeneSys Bio | 85% | |
| BIOPIX-T | 83% |
For institutional investors. Book with your work email.
Detechgene Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Aug 25, 2025 | ||||
| Grant | Jun 2, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Detechgene Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Meerkat Holding | Seed |
| neoteq ventures | Seed |
| NRW.Bank | Seed, Pre Seed |
| Aquarius Invest GmbH | Seed |
| Campus Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
DIAGURIN project launched within the gesünder.in.nrw initiative.
- Nov 9, 2025
Received founding category recognition for innovative PCR rapid test.
For institutional investors. Book with your work email.
Detechgene Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Detechgene's valuation, stock price, and market status.
Is Detechgene a public or private company?
Detechgene is a private company.
What is the current stock price of Detechgene?
Detechgene is a private company, so its shares have no public market price. Caplight tracks Detechgene's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Detechgene worth (valuation)?
Valuation information for Detechgene is not publicly available.
Can I buy Detechgene stock?
Detechgene shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Detechgene's last funding round?
Detechgene's most recent funding round was Seed on August 25, 2025.
Who are the main investors in Detechgene?
Key investors in Detechgene include neoteq ventures.
Will Detechgene IPO soon?
No public IPO plans have been announced for Detechgene.
How can I track Detechgene secondary market activity?
Caplight tracks bids, offers, and trades in Detechgene's shares on secondary markets.